No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs56161891 |
chr18:12062004-12062005 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs531664790 |
chr18:12062030-12062031 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs144537730 |
chr18:12062050-12062051 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs34339997 |
chr18:12062074-12062075 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs571388962 |
chr18:12062084-12062085 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs36061429 |
chr18:12062091-12062092 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs150341800 |
chr18:12062108-12062109 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs184151421 |
chr18:12062114-12062115 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs112710442 |
chr18:12062117-12062118 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs138065694 |
chr18:12062118-12062119 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs60505533 |
chr18:12062119-12062120 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs148543184 |
chr18:12062124-12062125 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs566626542 |
chr18:12062148-12062149 |
Weak transcription Genic enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs538731439 |
chr18:12062195-12062196 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs367779612 |
chr18:12062199-12062200 |
Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs145075157 |
chr18:12062242-12062243 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs79345699 |
chr18:12062254-12062255 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs58185239 |
chr18:12062255-12062256 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs78692826 |
chr18:12062257-12062258 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs371996669 |
chr18:12062319-12062320 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs28535741 |
chr18:12062334-12062335 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs188748745 |
chr18:12062336-12062337 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs373874327 |
chr18:12062360-12062361 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs534893351 |
chr18:12062364-12062365 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs556600701 |
chr18:12062365-12062366 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs578099844 |
chr18:12062366-12062367 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs528290716 |
chr18:12062367-12062368 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs545284496 |
chr18:12062368-12062369 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs68021189 |
chr18:12062369-12062370 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs575789939 |
chr18:12062375-12062376 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs181574271 |
chr18:12062416-12062417 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs553858559 |
chr18:12062422-12062423 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs536395803 |
chr18:12062423-12062424 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs542628566 |
chr18:12062431-12062432 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs560893538 |
chr18:12062453-12062454 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs555152535 |
chr18:12062459-12062460 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs531226588 |
chr18:12062476-12062477 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs186127622 |
chr18:12062477-12062478 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs565041513 |
chr18:12062485-12062486 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs113349329 |
chr18:12062553-12062554 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs28567958 |
chr18:12062582-12062583 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
42 |
rs34222301 |
chr18:12062597-12062598 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs547235072 |
chr18:12062603-12062604 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs566618384 |
chr18:12062623-12062624 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs527815898 |
chr18:12062672-12062673 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs540957491 |
chr18:12062691-12062692 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs567622573 |
chr18:12062703-12062704 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs537871214 |
chr18:12062724-12062725 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs190479288 |
chr18:12062732-12062733 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs550410996 |
chr18:12062742-12062743 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|